These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18471161)

  • 21. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
    Ullmann AJ
    Curr Med Res Opin; 2003; 19(4):263-71. PubMed ID: 12841918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study).
    Jarque I; Tormo M; Bello JL; Rovira M; Batlle M; Julià A; Tabares S; Rivas C; Fernández-Sevilla A; García-Boyero R; Debén G; González-Campos J; Capote FJ; Sanz MA;
    Med Mycol; 2013 Feb; 51(2):150-4. PubMed ID: 22712457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin.
    Cooke FJ; Terpos E; Boyle J; Rahemtulla A; Rogers TR
    Clin Microbiol Infect; 2003 Dec; 9(12):1238-41. PubMed ID: 14686991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
    Maertens J; Raad I; Petrikkos G; Boogaerts M; Selleslag D; Petersen FB; Sable CA; Kartsonis NA; Ngai A; Taylor A; Patterson TF; Denning DW; Walsh TJ;
    Clin Infect Dis; 2004 Dec; 39(11):1563-71. PubMed ID: 15578352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungal infections in solid organ transplantation.
    Marik PE
    Expert Opin Pharmacother; 2006 Feb; 7(3):297-305. PubMed ID: 16448324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.
    Maschmeyer G; Haas A; Cornely OA
    Drugs; 2007; 67(11):1567-601. PubMed ID: 17661528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echinocandin antifungal drugs.
    Denning DW
    Lancet; 2003 Oct; 362(9390):1142-51. PubMed ID: 14550704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
    Baddley JW; Andes DR; Marr KA; Kauffman CA; Kontoyiannis DP; Ito JI; Schuster MG; Brizendine KD; Patterson TF; Lyon GM; Boeckh M; Oster RA; Chiller T; Pappas PG
    Med Mycol; 2013 Feb; 51(2):128-35. PubMed ID: 22680976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
    Kartsonis NA; Saah AJ; Joy Lipka C; Taylor AF; Sable CA
    J Infect; 2005 Apr; 50(3):196-205. PubMed ID: 15780413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
    Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
    Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
    Chirch L; Roche P; Fuhrer J
    Ear Nose Throat J; 2008 Jan; 87(1):30-3. PubMed ID: 18357943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of caspofungin for treating invasive nasal sinus aspergillosis in a kidney transplant recipient.
    Said T; Nampoory MR; Nair MP; Al-Saleh M; Al-Haj KH; Halim MA; Johny KV; Samhan M; Al-Mousawi M
    Transplant Proc; 2005 Sep; 37(7):3038-40. PubMed ID: 16213297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Addressing the "Hot Spots" in the management of invasive aspergillosis].
    Kontoyiannis D
    Med Mal Infect; 2007; 37 Suppl 2():9-11. PubMed ID: 17933659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of caspofungin in critically ill patients. ProCAS Study.
    León-Gil C; Ubeda-Iglesias A; Loza-Vázquez A; de la Torre MV; Raurich-Puigdevall JM; Alvarez-Sánchez B; Ortiz-Leyva C; Domínguez-Roldán JM; Socías-Crespi L; Garnacho-Montero J;
    Rev Esp Quimioter; 2012 Dec; 25(4):274-82. PubMed ID: 23303260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micafungin for the treatment of invasive aspergillosis.
    Enoch DA; Idris SF; Aliyu SH; Micallef C; Sule O; Karas JA
    J Infect; 2014 Jun; 68(6):507-26. PubMed ID: 24480373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy and tolerability of caspofungin in a renal transplant patient with Aspergillus flavus lung infection: case report.
    Pasticci MB; Barchiesi F; Fallani S; Palladino N; Lapalorcia LM; Gubbiotti M; Cozzari M; Novelli A; Baldelli F
    J Chemother; 2006 Oct; 18(5):549-53. PubMed ID: 17127234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis.
    Maertens J
    Int J Antimicrob Agents; 2006 Jun; 27(6):457-67. PubMed ID: 16701980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caspofungin.
    Deresinski SC; Stevens DA
    Clin Infect Dis; 2003 Jun; 36(11):1445-57. PubMed ID: 12766841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.